tion domain binding protein and was shown to coactivate JUN-mediated gene expression (24 ) . Recently, mammalian JAB1 was reported to bind a number of other proteins: The lutropin/choriogonadotropin receptor (25) and CDK inhibitor p27 (26 ) are targeted for degradation by JAB1, whereas signals propagated by the LFA1 integrin (27 ) and MIF cytokine (28) modulate JAB1 by an unknown mechanism(s). Our work suggests that a key function of the JAB1-containing CSN is to promote cleavage of NEDD8 from cullins and other NEDD8-modified proteins, and that the defects of CSN mutants arise from a failure to cleave NEDD8 from specific substrates. For example, failure to remove NEDD8 from COP1, HY5, or an affiliated protein may constitutively activate light-dependent gene expression in A. thaliana by blocking COP1-dependent turnover of the photomorphogenetic regulator HY5 (29) .
The functional impact of CSN on its substrates is difficult to predict. NEDD8 attachment is essential in vivo (19) and promotes SCF ␤-TRCP activity in vitro (3), but conversely, diminished CSN function inhibits turnover of an SCF TIR1 target in A. thaliana (30) . Thus, NEDD8 may need to be cyclically attached to and cleaved from CUL1 for optimal SCF function. Cycles of neddylation, like cycles of protein phosphorylation, may serve different functions in different contexts. Nonetheless, given the potentially large number of cullin-based ubiquitin ligases and the observed accumulation of additional NEDD8-modified proteins in ⌬caa1 cells, CSN is likely to modulate a broad range of biological processes. conform to existing nomenclature and make it easier to discern the origin of proteins referred to in the text. 17 phenyl)amino)hexanoyl)-1-palmitoyl-2-BODIPY-FL-pentanoyl-sn-glycero-3-phosphoethanolamine (PED6) (2)] allow subcellular visualization of PLA 2 activity in zebrafish embryos (1) and reveal organspecific activity (9). Larvae [5 days postfertilization (dpf )] bathed in PED6 show intense gall bladder fluorescence and, shortly thereafter, intestinal luminal fluorescence (Fig. 1C ). Larvae were bathed in an unquenched fluorescent lipid to confirm that lipids were swallowed (Fig. 1D) . We determined that PED6 is cleaved within the intestine, because PLA 2 activity was not detected in bile (10) and fluorescent PED6 metabolites underwent rapid hepatobiliary transport, labeling the liver before the gall bladder (Fig. 1E) . Moreover, PED6 labeling of the gall bladder was completely blocked by atorvastatin (Lipitor, Parke-Davis) (Fig. 1F) , a potent inhibitor of cholesterol synthesis in humans (11) . Because the addition of exogenous bile reversed this effect (12) , and atorvastatin failed to inhibit processing of a water-soluble shortchain fatty acid (BODIPY FL-C5, Molecular Probes Inc.) (7) (Fig. 1G) , we hypothesize that atorvastatin blocks the synthesis of cholesterol-derived biliary emulsifiers needed for dietary lipid absorption (13, 14) . These results, coupled with the rapid appearance of biliary fluorescence in mice fed PED6 (Fig.  1, H and I) , demonstrate that PED6 metabolism in zebrafish corresponds to established mechanisms of lipid processing in mammals (15) .
To determine the site of PLA 2 activity more precisely, we developed a substrate [BODIPY FR-PC ( Fig. 2A) ] that emits distinct fluorescent profiles before and after cleavage (16) . This phospholipid contains two dyes that interact via fluorescence resonance energy transfer (FRET) (17) . The substrate and cleavage product have unique spectral signatures, allowing their tissue distribution to be distinguished by fluorescence microscopy. Excitation (505 nm) of micelleincorporated BODIPY FR-PC produces an orange emission (568 nm; Fig. 2B ) from the sn2 fluorophore via the FRET effect (18) . However, cleavage of the substrate by puri- fied PLA 2 releases the sn2 acyl chain and abolishes FRET (Fig. 2B) . Excitation of the resultant lysolipid produces a green emission (515 nm).
Within 1 hour, larvae bathed in BODIPY FR-PC showed a bright green fluorescent gall bladder and orange fluorescence within the apical cytoplasm of posterior intestinal cells (Fig. 2C) . These cells are known to absorb luminal macromolecules through pinocytosis (19) . Orange fluorescence indicative of uncleaved substrate was also observed in the anterior intestine epithelium, the site of lipid absorption in fish (6, 20) . FRET emission (orange) was never detected in the liver even after prolonged incubation (Fig. 2D) , supporting the hypothesis that gall bladder fluorescence after ingestion of labeled lipids is due to cleavage by intestinal PLA 2 .
To use fluorescent lipid assays for genetic screening, we first examined PED6 processing in mutants known to perturb intestinal morphology in a region-specific manner (21) . The mutations slim jim (slj) and piebald (pie) each cause degeneration of anterior intestinal epithelium and exocrine pancreas, whereas meltdown (mlt) results in cystic expansion of the posterior intestine. As shown in Fig. 3, A and B, mlt mutants retain PED6 processing in the anterior intestine and show normal levels of gall bladder fluorescence. In contrast, pie (Fig. 3, C and D) and slj (Fig. 3E ) mutants display greatly reduced gall bladder labeling. Hence, fluorescent lipids can be used to identify mutants with abnormal digestive organ morphology.
Lipid reporters have also proven effective for identifying mutations that perturb lipid metabolism without causing obvious morphological defects. In a pilot screen, larval progeny of individual F 2 families derived from an ENU mutagenesis protocol (22) were bathed in PED6 and screened for digestive organ morphology and phospholipid processing. PED6 fluorescent metabolites enhance visibility of digestive organ structure, facilitating scoring of gall bladder development, intestinal folding, and bile duct morphology (23) . Of the 190 genomes screened, two mutations were identified and confirmed in the subsequent generation. The recessive lethal mutation canola produces a phenotype closely resembling that of slj and pie, with degeneration of the intestinal epithelium and reduced gall bladder and intestinal fluorescence (24) . The fat free recessive lethal mutation causes a more pronounced reduction in fluorescence (Fig. 4B) . However, in contrast to canola and other intestinal mutants, the fat free digestive tract has a normal appearance at 5 dpf (Fig. 4A) . Therefore, fat free would have escaped detection in a screen based solely on morphological criteria.
To determine how the fat free mutation affects larval digestive physiology, we first determined that swallowing was normal in mutants by their ingestion of fluorescent beads (25) . Next, we demonstrated that the fat free hepatobiliary system was functional by monitoring biliary excretion of the organic anion phenol red (Fig. 4C) (26) . Thin-layer chromatography (TLC) of metabolites produced by fat free larvae labeled with an unquenched BODIPY phosphatidylcholine analog (1) revealed that PLA 2 processing was intact (27) . However, extracts prepared from mutants contained significantly reduced levels of fluorescent cleavage products (Fig. 4D) .
Lipid processing was further examined using a fluorescent cholesterol analog (28) whose absorption is dependent on biliary emulsification. Cholesterol was poorly absorbed by fat free larvae (Fig. 4E) . Because uptake of BODIPY FL-C5, a more soluble short-chain fatty acid, was reduced to a lesser extent than uptake of cholesterol and PED6 (24), we propose that fat free directly regulates bile synthesis or secretion rather than intestinal lipid absorption or transport. Further, the zebrafish fat free mutation provides in vivo evidence supporting the hypothesis, derived from mammalian cell culture experiments, that phospholipid turnover and cholesterol metabolism are coupled (29) .
Mutagenesis screens using fluorescent lipids exploit the advantages of zebrafish for combining genetic analyses with imaging of enzymatic function. The existence of related lipid processing mechanisms in mammals and teleosts, and the finding that therapeutic drugs used to modify lipid metabolism in humans are active in zebrafish, suggest that genetic screens can be designed to probe the mechanistic basis of acquired and heritable human disorders. Fluorescent reporters are predicted to identify genes involved in diseases of lipid metabolism, such as atherosclerosis; in disorders of biliary secretion, such as biliary atresia; and in cancer, a disease in which lipid signaling plays an important role.
